Sahli Z, Bizri A, Abu-Sittah G
Epidemiol Infect. 2016; 144(13):2848-57.
PMID: 26931769
PMC: 9150393.
DOI: 10.1017/S0950268816000431.
Kong K, Schneper L, Mathee K
APMIS. 2010; 118(1):1-36.
PMID: 20041868
PMC: 2894812.
DOI: 10.1111/j.1600-0463.2009.02563.x.
Wininger D, Fass R
Antimicrob Agents Chemother. 2002; 46(2):594-7.
PMID: 11796387
PMC: 127034.
DOI: 10.1128/AAC.46.2.594-597.2002.
Casadevall A, Pirofski L
Infect Immun. 2000; 68(12):6511-8.
PMID: 11083759
PMC: 97744.
DOI: 10.1128/IAI.68.12.6511-6518.2000.
Kuikka A, Sivonen A, Emelianova A, Valtonen V
Eur J Clin Microbiol Infect Dis. 1997; 16(2):125-34.
PMID: 9105839
DOI: 10.1007/BF01709471.
Future prospects and therapeutic potential of streptogramins.
Rubinstein E, Keller N
Drugs. 1996; 51 Suppl 1:38-42.
PMID: 8724815
DOI: 10.2165/00003495-199600511-00008.
In vitro activity of chloramphenicol and thiamphenicol analogs.
Neu H, Fu K
Antimicrob Agents Chemother. 1980; 18(2):311-6.
PMID: 7447408
PMC: 283989.
DOI: 10.1128/AAC.18.2.311.
Influence of laboratory reports on prescribing of antimicrobials for urinary tract infection.
Barnes M
J Clin Pathol. 1980; 33(5):481-3.
PMID: 7400346
PMC: 1146114.
DOI: 10.1136/jcp.33.5.481.
Antibiotic misuse in a pediatric teaching hospital.
Schollenberg E, Albritton W
Can Med Assoc J. 1980; 122(1):49-52.
PMID: 7363195
PMC: 1801611.
Positive blood cultures in a university hospital in The Netherlands.
Michel M, Priem C
Infection. 1981; 9(6):283-9.
PMID: 7333680
DOI: 10.1007/BF01640992.
Septic shock--an update.
Kumar A
Indian J Pediatr. 1982; 49(400):745-50.
PMID: 7188198
PMC: 7101567.
DOI: 10.1007/BF02752663.
In vitro and in vivo activity of DL-8280, a new oxazine derivative.
Sato K, Matsuura Y, Inoue M, Une T, Osada Y, Ogawa H
Antimicrob Agents Chemother. 1982; 22(4):548-53.
PMID: 6960805
PMC: 183791.
DOI: 10.1128/AAC.22.4.548.
Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility.
Legakis N, Aliferopoulou M, Papavassiliou J, Papapetropoulou M
J Clin Microbiol. 1982; 16(3):458-63.
PMID: 6813351
PMC: 272389.
DOI: 10.1128/jcm.16.3.458-463.1982.
In vitro antibacterial activity of AM-715, a new nalidixic acid analog.
Ito A, Hirai K, Inoue M, Koga H, SUZUE S, IRIKURA T
Antimicrob Agents Chemother. 1980; 17(2):103-8.
PMID: 6446258
PMC: 283741.
DOI: 10.1128/AAC.17.2.103.
Bactericidal effect of combinations of nalidixic acid and various antibiotics on Enterobacteriaceae.
Michel J, Luboshitzky R, Sacks T
Antimicrob Agents Chemother. 1973; 4(3):201-4.
PMID: 4758830
PMC: 444529.
DOI: 10.1128/AAC.4.3.201.
Editorial: "Prolixity will be construed as uncertainty".
SANFORD J
Calif Med. 1973; 119(5):50-1.
PMID: 4755694
PMC: 1455300.
In vitro antibiotic susceptibility of pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients.
Moody M, YOUNG V, Kenton D
Antimicrob Agents Chemother. 1972; 2(5):344-9.
PMID: 4670506
PMC: 444318.
DOI: 10.1128/AAC.2.5.344.
The effect of passage and iron on the virulence of Pseudomonas aeruginosa.
Forsberg C, BULLEN J
J Clin Pathol. 1972; 25(1):65-8.
PMID: 4622627
PMC: 477224.
DOI: 10.1136/jcp.25.1.65.
Prescription of antimicrobial drugs by general practitioners.
Hemminki E, Forsman H, Hemminki K
Infection. 1974; 2(4):203-6.
PMID: 4443083
DOI: 10.1007/BF01641463.
Editorial: Endotoxaemia.
Br Med J. 1974; 4(5947):730.
PMID: 4441875
PMC: 1612792.
